FrancophonIA/ELRC3.0 huggingface dataset:
English: Ceftriaxone inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs).
Croatian: Ceftriakson se veže na proteine koji vezuju penicilin te tako inhibira sintezu stanične stijenke bakterije.
English: • Pain or a burning feeling along the vein where Rocephin has been given.
Croatian: • bol ili osjećaj žarenja duž vene u koju je Rocephin ubrizgan; bol na mjestu primjene injekcije • visoka temperatura (vrućica)
English: Use of lidocaine
Croatian: Primjena lidokaina
English: Route of administration: [To be completed nationally]
Croatian: Put primjene: [Ispunjava država članica]
English: 2 g powder for solution for infusion Intravenous use
Croatian: 2 g prašak za otopinu za infuziju
English: ceftriaxone (as ceftriaxone sodium)
Croatian: ceftriakson (u obliku ceftriaksonnatrija)
English: Ceftriaxone is contraindicated in: Premature neonates up to a postmenstrual age of 41 weeks (gestational age + chronological age)* Full-term neonates (up to 28 days of age): with hyperbilirubinaemia, jaundice, or who are hypoalbuminaemic or acidotic because these are conditions in which bilirubin binding is likely to be impaired* if they require (or are expected to require) intravenous calcium treatment, or calcium-containing infusions due to the risk of precipitation of a ceftriaxone-calcium salt (see sections 4.4, 4.8 and 6.2).
Croatian: - s hiperbilirubinemijom, žuticom, ili koji imaju hipoalbuminemiju ili acidozu, jer su to stanja kod kojih postoji vjerojatnost poremećaja u vezanju bilirubina* - kojoj je potrebno (ili se očekuje da će im biti potrebno) intravensko liječenje kalcijem ili infuzijama koje sadrže kalcij, zbog rizika od precipitacije sceftriaksona i soli kalcija (vidjeti dijelove 4.4, 4.8 i 6.2).
English: There is conflicting evidence regarding a potential increase in renal toxicity of aminoglycosides when used with cephalosporins.
Croatian: Dokazi o mogućem povećanju bubrežne toksičnosti kod primjene aminoglikozida u kombinaciji s cefalosporinima nisu jednoznačni.
English: Data to determine the frequency of ceftriaxone ADRs was derived from clinical trials.
Croatian: Podaci za utvrđivanje učestalosti nuspojava povezanih s primjenom ceftriaksona prikupljeni su u kliničkim ispitivanjima.
English: Very common (≥ 1/10)
Croatian: Za određivanje učestalosti korištene su sljedeće kategorije: vrlo često (≥ 1/10)
English: In particular diluents containing calcium, (e.g. Ringer's solution, Hartmann's solution) should not be used to reconstitute ceftriaxone vials or to further dilute a reconstituted vial for intravenous administration because a precipitate can form.
Croatian: Osobito se otapala koja sadrže kalcij (npr. Ringerova otopina ili Hartmannova otopina) ne smiju koristiti za rekonstituciju bočica ceftriaksona niti za daljnje razrjeđivanje rekonstituirane bočice za intravensku primjenu jer može doći do precipitacije.
English: • Loose stools or diarrhoea.
Croatian: • meka stolica ili proljev
English: Complicated skin and soft tissue infections Gonorrhoea
Croatian: Infekcije kosti i zglobova Komplicirane infekcije kože i mekih tkiva Gonoreja
English: Diluents containing calcium, (e.g. Ringer's solution or Hartmann's solution), should not be used to reconstitute ceftriaxone vials or to further dilute a reconstituted vial for intravenous administration because a precipitate can form.
Croatian: Razrjeđivači koji sadrže kalcij (npr. Ringerova otopina ili Hartmannova otopina) ne smiju se koristiti za rekonstituciju bočica ceftriaksona niti za daljnje razrjeđivanje rekonstituirane bočice za intravensku primjenu jer može doći do precipitacije.
English: • A lumpy rash (hives) that may cover a lot of your body, feeling itchy and swelling.
Croatian: • izdignut osip koji svrbi (koprivnjača) i koji može prekrivati velik dio tijela, svrbež i natečenost
English: Germany, Greece, Hungary, Ireland, Netherlands, Portugal: Rocephin Italy: Rocefin
Croatian: Njemačka, Grčka, Mađarska, Irska, Nizozemska, Portugal: Rocephin
English: Germany, Hungary, Netherlands, Portugal: Rocephin Italy: Rocefin
Croatian: Njemačka, Mađarska, Nizozemska, Portugal: Rocephin
English: Convulsions.
Croatian: • konvulzije
English: Nervous system disorders
Croatian: Poremećaji živčanog sustava glavobolja omaglica konvulzija
English: Dilution Test (MIC, mg/L)
Croatian: (MIK, mg/l) Osjetljiv
English: The most frequently reported adverse reactions for ceftriaxone are eosinophilia, leucopenia, thrombocytopenia, diarrhoea, rash, and hepatic enzymes increased.
Croatian: Najčešće prijavljene nuspojave kod liječenja ceftriaksonom su eozinofilija, leukopenija,
English: Adults and children over 12 years of age (≥ 50 kg)
Croatian: Odrasli i djeca starija od 12 godina (≥ 50 kg) Doza ceftriaksona*
English: Intra-abdominal infections
Croatian: Akutni otitis media Intraabdominalne infekcije
English: No impairment of renal function has been observed after concurrent administration of large doses of ceftriaxone and potent diuretics (e.g. furosemide).
Croatian: Nakon istodobne primjene velikih doza ceftriaksona i snažnih diuretika (npr. furosemida) nije primijećeno oštećenje bubrežne funkcije.
English: Not known (cannot be estimated from the available data)
Croatian: Teški kožni osipi (nepoznato, učestalost se ne može procijeniti iz dostupnih podataka).
English: Disseminated Lyme borreliosis (early [Stage II] and late [Stage III]) 2 g once daily for 14-21 days.
Croatian: Diseminirana lajmska borelioza (rana [stadij II] i kasna [stadij III])
English: Severe allergic reactions (not known, frequency cannot be estimated from the available data) If you have a severe allergic reaction, tell a doctor straight away.
Croatian: Teške alergijske reakcije (nepoznato, učestalost se ne može procijeniti iz dostupnih podataka).
English: The signs include severe pain in the stomach which spreads to your back.
Croatian: • vrtoglavica (osjećaj da se sve oko Vas okreće) • upala gušterače (pankreatitis); znakovi uključuju jaku bol u trbuhu koja se širi prema leđima
English: • Pruritis (itching).
Croatian: • svrbež (pruritus)
English: Chlamydophila spp.
Croatian: Chlamydophila spp. Mycoplasma spp.
English: MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally]
Croatian: Nositelj odobrenja za stavljanje gotovog lijeka u promet i proizvođač [Vidjeti Dodatak I - ispunjava država članica]
English: 1-2 g
Croatian: 2 g x 1.
English: An immune mediated haemolytic anaemia has been observed in patients receiving cephalosporin class antibacterials including Rocephin (see section 4.8).
Croatian: U bolesnika koji su primali antibiotike iz skupine cefalosporina, uključujući Rocephin, primijećena je imunološki posredovana hemolitička anemija (vidjeti dio 4.8).
English: Peptostreptococcus spp.
Croatian: Peptostreptococcus spp. Clostridium perfringens
English: Ceftriaxone penetrates the meninges.
Croatian: Ceftriakson prodire kroz moždane ovojnice.
English: PHARMACEUTICAL FORM AND CONTENTS [To be completed nationally]
Croatian: NAČIN IZDAVANJA LIJEKA [Ispunjava država članica]
English: Rarely, severe, and in some cases, fatal, adverse reactions have been reported in pre-term and full-term neonates (aged < 28 days) who had been treated with intravenous ceftriaxone and calcium.
Croatian: U nedonoščadi i terminske novorođenčadi (u dobi < 28 dana) liječene intravenskim ceftriaksonom i kalcijem rijetko su prijavljene teške nuspojave koje su ponekad imale smrtni ishod.
English: Skin and subcutaneous tissue disorders
Croatian: Poremećaji kože i potkožnog tkiva osip pruritus urtikarija
English: Rocephin 250 mg Powder and Solvent for Solution for Injection Hungary, Portugal: Rocephin
Croatian: Rocephin 250 mg prašak za otopinu za injekciju Malta, Nizozemska, Velika Britanija: Rocephin
English: Intra-abdominal infections Complicated skin and soft tissue infections Complicated urinary tract infections (including pyelonephritis)
Croatian: 1-2 g jedanput na dan izvanbolnički stečena pneumonija akutne egzacerbacije kronične opstruktivne plućne bolesti intraabdominalne infekcije komplicirane infekcije mokraćnog sustava (uključujući pijelonefritis)
English: A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from ceftriaxone therapy, taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Croatian: Uzimajući u obzir korist dojenja za dijete i dobrobit liječenja za majku, mora se donijeti odluka hoće li se prekinuti dojenje ili privremeno ili trajno prekinuti liječenje ceftriaksonom.
English: Ceftriaxone dosage*
Croatian: Doza ceftriaksona* Učestalost primjene**
English: Ceftriaxone-calcium salt precipitation
Croatian: Precipitacija ceftriaksona i soli kalcija
English: Patients with renal or hepatic impairment
Croatian: Bolesnici s oštećenjem bubrežne ili jetrene funkcije
English: You have ever had problems with your gut, in particular colitis (inflammation of the bowel).
Croatian: osobito kolitis (upalu crijeva)
English: What Rocephin contains
Croatian: Što Rocephin sadrži [Ispunjava država članica]
English: 250 mg powder for solution for injection Powder for solution for injection [To be completed nationally]
Croatian: 250 mg prašak za otopinu za injekciju Prašak za otopinu za injekciju
English: 100 mg/kg (max 4 g)
Croatian: 4 g) jedanput na dan bakterijski meningitis 100 mg/kg (maks.
English: Gastrointestinal disorders
Croatian: Test razrjeđivanja
English: 6.6 Special precautions for disposal <and other handling>
Croatian: 6.4 Posebne mjere pri čuvanju lijeka [Ispunjava država članica]
English: The signs include diarrhoea, usually with blood and mucus,
Croatian: • upala debelog crijeva; znakovi uključuju proljev, u kojem obično ima krvi i sluzi, bol u trbuhu i vrućicu
English: Calcium-containing diluents, such as Ringer's solution or Hartmann's solution, should not be used to reconstitute Rocephin vials or to further dilute a reconstituted vial for intravenous administration because a precipitate can form.
Croatian: 4.5 Interakcije s drugim lijekovima i drugi oblici interakcija Otapala koja sadrže kalcij, poput Ringerove otopine ili Hartmannove otopine, ne smiju se koristiti za rekonstituciju Rocephin bočica niti za daljnje razrjeđivanje rekonstituirane bočice za intravensku primjenu jer može doći do stvaranja precipitata.
English: Nausea Vomiting
Croatian: • mučnina ili povraćanje
English: The generally recommended doses are 75-100 mg/kg (max 4 g) once daily for 10-14 days.
Croatian: Sifilis Uobičajene preporučene doze su 75-100 mg/kg (maks.
English: Cases of pancreatitis, possibly of biliary obstruction aetiology, have been reported in patients treated with Rocephin (see section 4.8).
Croatian: U bolesnika liječenih lijekom Rocephin prijavljeni su slučajevi pankreatitisa, koji bi mogli biti posljedica opstrukcije žučnih vodova (vidjeti dio 4.8).
English: Rocephin and associated names (see Annex I) 2 g Powder for Solution for Infusion Rocephin and associated names (see Annex I) 2 g Powder for Solution for Injection or Infusion Rocephin and associated names (see Annex I) 1 g Powder for Solution for Injection or Infusion Rocephin and associated names (see Annex I) 1 g Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 500 mg Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 250 mg Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 250 mg Powder for Solution for Injection
Croatian: Rocephin i pridružena imena (vidjeti Dodatak I) 2 g prašak za otopinu za infuziju Rocephin i pridružena imena (vidjeti Dodatak I) 2 g prašak za otopinu za injekciju ili infuziju Rocephin i pridružena imena (vidjeti Dodatak I) 1 g prašak za otopinu za injekciju ili infuziju Rocephin i pridružena imena (vidjeti Dodatak I) 1 g prašak i otapalo za otopinu za injekciju Rocephin i pridružena imena (vidjeti Dodatak I) 500 mg prašak i otapalo za otopinu za injekciju Rocephin i pridružena imena (vidjeti Dodatak I) 250 mg prašak i otapalo za otopinu za injekciju Rocephin i pridružena imena (vidjeti Dodatak I) 250 mg prašak za otopinu za injekciju
English: Oliguria Renal precipitation (reversible)
Croatian: Poremećaji bubrega i mokraćnog sustava hematurija glikozurija oligurija precipitacija u bubrezima (reverzibilna)
English: It is recommended that the International Normalised Ratio (INR) is monitored frequently and the posology of the anti-vitamin K drug adjusted accordingly, both during and after treatment with ceftriaxone (see section 4.8).
Croatian: Preporučuje se česta kontrola internacionalnog normaliziranog omjera (INR) te odgovarajuća prilagodba doze lijekova antagonista vitamina
English: France: Rocephine
Croatian: Belgija, Luksemburg: Rocephine
English: GENERAL CLASSIFICATION FOR SUPPLY [To be completed nationally]
Croatian: POPIS POMOĆNIH TVARI [Ispunjava država članica]
English: Non enzymatic methods for glucose determination false positiveb a Based on post-marketing reports.
Croatian: Pretrage povišena vrijednost kreatinina u krvi lažno pozitivan nalaz Coombsova testab lažno pozitivan nalaz testa na galaktozemijub lažno pozitivan nalaz kod neenzimskih metoda za određivanje razine glukozeb a Na temelju prijava nakon stavljanja lijeka u promet.
English: Once daily
Croatian: Manje često
English: • Inflammation of the tongue (glossitis).
Croatian: • mozga (meningitis)
English: Complicated skin and soft tissue infections Infections of bones and joints Management of neutropenic patients with fever that is suspected to be due to a bacterial infection
Croatian: 4 g) jedanput na dan komplicirane infekcije kože i mekih tkiva infekcije kosti i zglobova liječenje bolesnika s neutropenijom i vrućicom za koju se sumnja da je posljedica bakterijske infekcije 80-100 mg/kg (maks.
English: 2 g powder for solution for infusion Powder for solution for infusion [To be completed nationally]
Croatian: 2 g prašak za otopinu za infuziju Za primjenu u venu
English: Patients with renal impairment
Croatian: Bolesnici s oštećenjem jetrene funkcije
English: Method of administration
Croatian: UPUTE ZA UPORABU
English: Haematuria Glycosuria
Croatian: • omaglica
English: Rocephin can cause dizziness.
Croatian: Upravljanje vozilima i strojevima Rocephin može izazvati omaglicu.
English: the urinary tract and kidneys.
Croatian: • mokraćnog sustava i bubrega
English: The full EPAR and risk management plan summary for Praxbind can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR, kao i sažetak plana upravljanja rizikom za lijek Praxbind, nalaze se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: What is Praxbind and what is it used for?
Croatian: Što je Praxbind i za što se koristi?
English: What measures are being taken to ensure the safe and effective use of Praxbind?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Praxbind?
English: Why is Praxbind approved?
Croatian: Zašto je Praxbind odobren?
English: The medicine can only be obtained with a prescription and it is for use in hospital only.
Croatian: Lijek se izdaje samo na liječnički recept i koristi se samo u bolnicama.
English: It is not intended to provide practical advice on how to use Praxbind.
Croatian: Svrha sažetka nije davati praktične savjete o načinu korištenja lijeka Praxbind.
English: In a still ongoing trial, an interim analysis showed similar results in 123 patients who had uncontrolled bleeding or required emergency surgery while using Pradaxa.
Croatian: U kliničkom ispitivanju koje i dalje traje, privremena analiza pokazala je slične rezultate u 123 bolesnika koji su patili od nekontroliranog krvarenja ili kojima je bio potreban hitan kirurški zahvat tijekom primjene lijeka Pradaxa.
English: In the studies, volunteers received either Praxbind or placebo (a dummy treatment) after treatment with Pradaxa for 3.5 days.
Croatian: U ispitivanjima su dobrovoljci primali Praxbind ili placebo (prividno liječenje) nakon terapije lijekom Pradaxa u trajanju od 3,5 dana.
English: At the time of authorisation Praxbind has not been associated with any specific side effects.
Croatian: U vrijeme odobrenja Praxbind nije bio povezan ni s jednom specifičnom nuspojavom.
English: Praxbind has been investigated in three main studies involving 141 healthy adults who previously received dabigatran.
Croatian: Praxbind je ispitivan u trima glavnim ispitivanjima koja uključuju 141 zdravog dobrovoljca koji je prethodno primao dabigatran.
English: A second 5-g dose may be given as two further injections or infusions, if needed.
Croatian: Druga doza od 5 g može se prema potrebi dati u obliku dvije dodatne injekcije ili infuzije.
English: This is a summary of the European public assessment report (EPAR) for Praxbind.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Praxbind.
English: What are the risks associated with Praxbind?
Croatian: Koji su rizici povezani s lijekom Praxbind?
English: Praxbind is available as a solution for injection or infusion (drip) into a vein.
Croatian: Praxbind je dostupan kao otopina za injekciju ili infuziju (drip) u venu.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) therefore decided that Praxbind's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji odlučio je da koristi od lijeka Praxbind nadmašuju s njim povezane rizike te je preporučio njegovo odobrenje za primjenu u Europskoj uniji.
English: Most patients in the study were taking Pradaxa to prevent stroke due to an ‘abnormal heart beat' (atrial fibrillation).
Croatian: Većina bolesnika u ispitivanju uzimala je lijek Pradaxa za sprječavanje moždanog udara zbog "nepravilnih otkucaja srca" (atrijska fibrilacija).
English: A risk management plan has been developed to ensure that Praxbind is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Praxbind.
English: No side effects have been identified.
Croatian: Nisu utvrđene nuspojave.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Praxbind, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka, kao i u uputi o lijeku za lijek Praxbind, nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: For practical information about using Praxbind, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o korištenju lijeka Praxbind bolesnici trebaju pročitati u uputi o lijeku ili se obratiti svom liječniku ili ljekarniku.
English: The main studies showed that Praxbind is effective at neutralising the effects of Pradaxa, and its action is rapid, complete and sustained.
Croatian: Glavna ispitivanja pokazala su da je Praxbind djelotvoran u neutraliziranju učinaka lijeka Pradaxa te da je njegovo djelovanje brzo, potpuno i održivo.
English: A monoclonal antibody is a type of protein that has been designed to recognise and attach to a specific structure (called an antigen).
Croatian: Monoklonalno protutijelo vrsta je bjelančevine osmišljene za prepoznavanje i vezivanje za određenu strukturu (antigen).
English: The extent of Praxbind's benefit depends on the patient's overall health, the severity of bleeding and the location of bleeding.
Croatian: Stupanj koristi lijeka Praxbind ovisi o općem zdravlju bolesnika, te o ozbiljnosti i mjestu krvarenja.
English: For more information about treatment with Praxbind, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Praxbind pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: Results showed that Praxbind was able to completely neutralise Pradaxa's anticlotting effect within 5 minutes of use.
Croatian: Rezultati su pokazali da je Praxbind mogao potpuno neutralizirati antikoagulacijski učinak lijeka Pradaxa unutar 5 minuta od primjene.
English: The recommended dose of Praxbind is 5 g given into a vein as two injections or infusions, one after the other.
Croatian: Preporučena je doza lijeka Praxbind 5 g, a daje se u venu u obliku dvije injekcije ili infuzije, jedna za drugom.
English: Praxbind is used to rapidly stop the anticlotting effect of dabigatran, before emergency surgery or in case of life-threatening bleeding.
Croatian: Praxbind se koristi za ubrzani prekid antikoagulacijskog učinka dabigatrana prije hitnog kirurškog zahvata ili u slučaju po život opasnog krvarenja.
English: Praxbind is a medicine used to neutralise the effects of dabigatran (the active substance of Pradaxa), a medicine that treats and prevents blood clots.
Croatian: Praxbind je lijek koji se koristi za neutralizaciju učinka dabigatrana (djelatne tvari lijeka Pradaxa) kojim se liječi i sprečava krvne ugruške.
English: Other information about Praxbind
Croatian: Ostale informacije o lijeku Praxbind
English: How is Praxbind used?
Croatian: Kako se Praxbind koristi?
English: What benefits of Praxbind have been shown in studies?
Croatian: Koje su koristi lijeka Praxbind utvrđene u ispitivanjima?
English: How does Praxbind work?
Croatian: Kako djeluje Praxbind?
English: Praxbind works by attaching firmly to dabigatran, and forming a complex in the blood.
Croatian: Praxbind djeluje čvrstim vezivanjem na dabigatran i formiranjem kompleksa u krvi, što brzo prekida antikoagulacijski učinak dabigatrana.
English: The active substance in Praxbind, idarucizumab, is a monoclonal antibody fragment.
Croatian: Djelatna tvar lijeka Praxbind, idarucizumab, fragment je monoklonalnog protutijela.
English: For the information on the restrictions with Praxbind, see the package leaflet.
Croatian: Potpuni popis ograničenja za lijek Praxbind potražite u uputi o lijeku.
English: Praxbind contains the active substance idarucizumab.
Croatian: Praxbind sadrži djelatnu tvar idarucizumab.
English: Further information on Delstrigo can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/delstrigo.
Croatian: Više informacija o lijeku Delstrigo nalazi se na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/delstrigo.
English: Delstrigo must not be used with certain medicines that may reduce its effectiveness.
Croatian: Delstrigo se ne smije primjenjivati u kombinaciji s određenim lijekovima koji mogu smanjiti njegovu djelotvornost.
English: Delstrigo keeps the amount of HIV in the blood at a low level.
Croatian: Delstrigo održava količinu HIV-a u krvi na niskoj razini.
English: In a study with 728 patients, 84% of patients treated with Delstrigo had undetectable levels of HIV in their blood (fewer than 40 copies/ml) after 48 weeks of treatment compared with 80% of patients given a combination of efavirenz, emtricitabine and tenofovir disoproxil.
Croatian: U ispitivanju na 728 bolesnika, 84 % bolesnika liječenih lijekom Delstrigo imalo je neznatne razine HIV-a u krvi (manje od 40 kopija/ml) nakon 48 tjedana terapije u usporedbi s 80 % bolesnika koji su primili kombinaciju efavirenza, emtricitabina i tenofovirdizoproksila.
English: What measures are being taken to ensure the safe and effective use of Delstrigo?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Delstrigo?
English: Other information about Delstrigo
Croatian: Ostale informacije o lijeku Delstrigo
English: Side effects reported with Delstrigo are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Delstrigo pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.